{"id":"W2782099884","doi":"10.1182/blood.v130.suppl_1.1812.1812","title":"Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Safety and Efficacy in Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM) Previously Treated with a Proteasome Inhibitor (PI) and in Whom Last Prior Therapy with Lenalidomide (LEN) Failed","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Royal Victoria Hospital; Vancouver General Hospital","funders":"","keywords":"Medicine; Pomalidomide; Internal medicine; Neutropenia; Multiple myeloma; Lenalidomide; Bortezomib; Clinical endpoint; Cohort; Adverse effect; Surgery; Population; Gastroenterology; Randomized controlled trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007952084,0.0002513871,0.0005038403,0.0002621756,0.0002503734,0.0006458163,0.0002197262,0.0002663377,0.001343086],"category_scores_gemma":[0.0008832075,0.0001310828,0.0005859709,0.0003189973,0.0002374899,0.0003124972,0.0003220319,0.0005660024,0.0002067291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006428457,"about_ca_system_score_gemma":0.0006014139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005332942,"about_ca_topic_score_gemma":0.001625317,"domain_scores_codex":[0.9997699,0.00009304642,0.0000247291,0.00004271297,0.00003537947,0.00003429551],"domain_scores_gemma":[0.9995939,0.00006886086,0.0001609552,0.00001689054,0.00001487154,0.0001444194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3284793,0.006651449,0.3923166,0.0008904574,0.001248626,0.001544016,0.0003638388,0.003716983,0.02187838,0.00052127,0.00599892,0.2363902],"study_design_scores_gemma":[0.06131656,0.246215,0.6573173,0.0002415776,0.001319183,0.003753601,0.0003139527,0.004683353,0.008256265,0.0008715702,0.0156678,0.00004382808],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944783,0.00233354,0.0002097354,0.0001645065,0.00001899179,0.0003082861,0.0009285614,0.0000267066,0.00153138],"genre_scores_gemma":[0.9974859,0.0006576776,0.0003422288,0.0001658573,0.00004181442,0.0001352248,0.0008424951,0.0000029561,0.0003258167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001343086,"threshold_uncertainty_score":0.004664242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01574568132597968,"score_gpt":0.2580557407215349,"score_spread":0.2423100593955552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}